About: Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована у вересні 2006 (uk) im September 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2006 (ast) scientific article published on 01 September 2006 (en)
publication date	wds:Q80186067-82F484A7-6920-4610-92E8-A9351EFB83D5
publication date	2006-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80186067-56B17E86-3A2B-4953-8F2B-4816E200B79B wds:Q80186067-5A5F50A6-9060-4FC7-AD59-99489E5953C3 wds:Q80186067-64B96763-FCED-4098-B029-B427076043EB wds:Q80186067-654FDF67-1458-4E06-8753-CF1D96814BFB wds:Q80186067-6BE7D56E-FBDA-46CC-8705-0B2094E26149 wds:Q80186067-B907394A-2EA1-4846-93AC-7784BC9F2583 wds:Q80186067-BAD733BA-36D8-4B71-81FB-D94835EBFD58 wds:Q80186067-F7631598-C102-433D-992D-A1154DE7AAAA
author name string	Edwin Lewis Steven Black Thomas Cherian Paula Ray Henry Shinefield Janelle Lee John Hansen Jane Benson
rdfs:label	Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs (en) Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs (nl)
skos:prefLabel	Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs (en) Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs (nl)
name	Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs (en) Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs (nl)
author	wds:Q80186067-EC24ACBE-7648-429E-B60E-229BEF0E3A15
author	Bruce H Fireman
title	wds:Q80186067-0742C039-1E74-41B1-90C0-EA427C5D2EA0
title	Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs (en)
page(s)	wds:Q80186067-395D3F6A-B114-4326-B929-B1C6EC0E2D21
page(s)	779-781
instance of	wds:Q80186067-54F12F2A-1123-4894-A936-6308F7791246
instance of	scholarly article
main subject	wds:Q80186067-3FCBCBE0-1DD1-4E8B-A5D0-A45E2D8EB84B wds:Q80186067-6E9061DF-1CFB-4C47-9C8A-E004A13F6440 wds:Q80186067-D7F9EC1C-B732-4FE3-800B-3D64B7B1BE63 wds:Q80186067-FB4F70D9-B1D5-4B59-8443-D07686A10B0E
main subject	prevention vaccine pneumococcal conjugate vaccine World Health Organization
PubMed ID	wds:Q80186067-BF62719F-015A-4F4B-A8C6-A92B175233AC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16940833
PubMed ID	16940833
published in	wds:Q80186067-54675366-AD2E-477F-96BE-70E10D97F298
published in	Pediatric Infectious Disease Journal
issue	wds:Q80186067-4F02B4A2-DAB2-4F82-9DA4-4871AAA6AE5B
volume	wds:Q80186067-AD3F153F-594A-4174-9639-A0D7FDDA8D96
issue	9
volume	25
DOI	wds:Q80186067-5CC6B126-770C-43C5-9C83-C5CC9CBA1FE0
DOI	http://dx.doi.org/10.1097/01.INF.0000232706.35674.2F
DOI	10.1097/01.INF.0000232706.35674.2F
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80186067
is cites work of	Evaluation of the World Health Organization criteria for chest radiographs for pneumonia diagnosis in children Use of vaccines as probes to define disease burden Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination The future of pneumococcal disease prevention Estimating influenza-associated deaths in the United States Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis Pneumococcal pneumonia and influenza: a deadly combination Lessons learned from clinical trials evaluating pneumococcal conjugate vaccine efficacy against pneumonia and invasive disease Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines Vaccines to prevent pneumonia and improve child survival Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany Deletion of arcD in Streptococcus pneumoniae D39 impairs its capsule and attenuates virulence Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software